Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in HIV Patients with Tuberculosis Meningitis
NCT05590455Phase 2Recruiting
- Sponsor
- ANRS
- Start
- Apr 2023
- Primary completion
- Jun 2027
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of adalimumab in tuberculous meningitis (TBM), sponsored by ANRS. Started Apr 2023; status: recruiting.
02
Drugs
03
Conditions
tuberculous meningitis (TBM)
Beyond the preview
Go deeper on NCT05590455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05590455.